```html

X‑ray Induced Skin Burns

Overview

X‑ray induced skin burns (also known as radiation‑induced erythema or radiation dermatitis) are skin injuries that occur after exposure to high‑dose ionizing radiation, most commonly from diagnostic or therapeutic X‑ray procedures. The injury results from damage to the DNA and cellular structures of the epidermis and dermis, leading to inflammation, cell death, and, in severe cases, necrosis.

Although modern imaging equipment and strict safety protocols have dramatically reduced the incidence of severe burns, they still occur, especially in interventional radiology, fluoroscopy‑guided procedures, and radiation therapy where cumulative doses can be high. The exact prevalence is difficult to determine because many mild cases go unreported, but estimates from the American College of Radiology (ACR) suggest that clinically significant skin injury occurs in 0.5–2 % of patients undergoing high‑dose fluoroscopic procedures and in up to 5 % of patients receiving > 20 Gy in a single course of radiation therapy.<sup>[1][2]</sup>

Anyone who undergoes repeated or prolonged X‑ray exposure—such as patients receiving cardiac catheterizations, spinal interventions, oncology radiotherapy, or those who work in radiology without proper protective measures—can be affected.

Symptoms

Skin changes usually appear within hours to weeks after exposure, depending on the dose:

• Erythema (redness): The earliest sign, often resembling a sunburn. It may be localized to the entry site of the beam.
• Dry desquamation: Peeling or flaking of the skin without oozing; typically appears 1–2 weeks after exposure.
• Moist desquamation: Wet, weeping patches that develop 2–4 weeks after high‑dose exposure; the skin feels tender.
• Pain or burning sensation: Discomfort can range from mild tingling to severe burning pain.
• Edema (swelling): Localized swelling may accompany erythema.
• Hyperpigmentation or hypopigmentation: Darkening or lightening of the skin months after injury.
• Ulceration or necrosis: Full‑thickness skin loss in severe cases (> 30 Gy); may expose underlying tissue.
• Telangiectasia: Small, visible blood vessels that appear months to years after injury.
• Hair loss (epilation): Temporary in the irradiated area.

Causes and Risk Factors

Primary Causes

• High‑dose diagnostic procedures: Prolonged fluoroscopy (e.g., cardiac angiography, interventional neuroradiology), CT‑guided interventions.
• Radiation therapy: External beam therapy, brachytherapy, or stereotactic radiosurgery delivering > 2 Gy per fraction.
• Industrial or accidental exposure: X‑ray generators used in non‑medical settings without proper shielding.

Risk Factors

• Cumulative dose: Repeated procedures increase total skin dose.
• Beam angle & skin folds: Areas where the beam overlaps (e.g., groin, axilla) receive higher doses.
• Patient size: Larger patients require higher output, increasing skin dose.
• Age: Children’s skin is more radiosensitive.
• Comorbidities: Diabetes, peripheral vascular disease, or collagen disorders impair healing.
• Medications: Chemotherapy agents (e.g., 5‑fluorouracil, taxanes) and certain antibiotics (e.g., doxycycline) can potentiate radiation injury.
• Poor protective practices: Inadequate lead shielding, failure to use dose‑monitoring software.

Diagnosis

Diagnosis is clinical but supported by a thorough history, physical exam, and sometimes additional testing.

Step‑by‑step Approach

1. History: Document type of X‑ray procedure, number of exposures, estimated dose (if available), timing of symptom onset, and any radiosensitizing medications.
2. Physical Examination: Assess the size, depth, and characteristics of skin changes; map the area relative to the radiation field.
3. Dosimetry Review: When possible, retrieve dose‑area product (DAP) or cumulative skin dose from the imaging system.
4. Skin Biopsy: Reserved for atypical presentations to rule out infection, malignancy, or other dermatoses.
5. Imaging: Ultrasound or MRI may be used to evaluate underlying tissue if ulceration or necrosis is suspected.

Classification Systems

• RTOG/EORTC acute radiation toxicity grading: Grades 1–4 based on erythema, desquamation, and ulceration.
• CTCAE (Common Terminology Criteria for Adverse Events) version 5.0: Gives a standardized way to record severity for research and clinical documentation.

Treatment Options

Management focuses on symptom relief, promoting wound healing, and preventing infection. Treatment is tailored to the grade of injury.

General Measures

• Cool compresses (15‑20 min, 3–4 times daily) for erythema and pain.
• Avoid further radiation exposure to the affected area.
• Maintain a clean, dry wound environment.
• Use non‑adherent dressings (e.g., silicone mesh) for moist desquamation.

Medication‑Based Therapies

• Topical steroids: 0.1 %–0.5 % triamcinolone for grade 1–2 erythema; applied 2 × daily for up to 2 weeks.
• Topical antibiotics: Mupirocin or bacitracin for superficial ulcerations to prevent bacterial colonization.
• Systemic analgesics: NSAIDs for mild pain; opioids for severe pain under physician supervision.
• Growth factor creams: Silver‑sulfadiazine or recombinant human epidermal growth factor (rhEGF) have shown benefit in promoting re‑epithelialization (Cochrane Review 2020).<sup>[3]</sup>
• Hyperbaric oxygen therapy (HBOT): Considered for chronic non‑healing ulcers (> 4 weeks) when conventional care fails.

Procedural Interventions

• Debridement: Gentle mechanical debridement of necrotic tissue performed by a wound‑care specialist.
• Skin grafting: Split‑thickness grafts for full‑thickness defects.
• Laser therapy: Pulsed dye laser can reduce telangiectasia and erythema in late‑phase injuries.

Lifestyle & Supportive Care

• Nutrition: Protein‑rich diet (1.2–1.5 g/kg/day) and vitamin C/E supplementation to aid collagen synthesis.
• Smoking cessation: Nicotine impairs microvascular perfusion.
• Hydration: Adequate fluid intake supports tissue perfusion.

Living with X‑ray Induced Skin Burns

Chronic management often involves daily wound care and lifestyle adjustments.

• Wound‑care routine: Clean the area with saline, apply prescribed ointment, and cover with a sterile non‑adhesive dressing. Change dressings at least once daily or sooner if saturated.
• Sun protection: UV exposure can exacerbate pigmentation changes; use broad‑spectrum SPF 30+ sunscreen on healed skin.
• Clothing: Wear loose‑fitting, breathable fabrics to reduce friction and moisture buildup.
• Regular follow‑up: Schedule visits with a dermatologist or radiation oncologist every 2–4 weeks until the wound fully resolves.
• Psychological support: Visible skin changes can affect self‑esteem; counseling or support groups (e.g., American Cancer Society) are recommended.

Prevention

Most X‑ray induced burns are preventable with proper protocol adherence.

1. Adhere to ALARA principle (As Low As Reasonably Achievable): Optimize exposure settings, limit fluoroscopy time, and use pulsed rather than continuous beams.
2. Use dose‑monitoring software: Real‑time skin dose maps alert clinicians when cumulative dose approaches threshold (e.g., 2 Gy).
3. Shielding: Apply lead aprons, thyroid collars, and custom lead patches over skin areas that will receive repeated exposure.
4. Patient positioning: Rotate beam angles to avoid “hot spots,” especially during lengthy procedures.
5. Educate staff: Ongoing radiation safety training for technologists, nurses, and physicians.
6. Pre‑procedure assessment: Identify high‑risk patients (e.g., prior radiation, diabetes) and consider alternative imaging (MRI, ultrasound).
7. Document dose: Include cumulative skin dose in the patient’s electronic health record for future reference.

Complications

If not managed appropriately, skin burns can lead to serious sequelae:

• Infection: Superinfection with Staphylococcus aureus or Pseudomonas can progress to cellulitis or sepsis.
• Chronic ulceration: Non‑healing wounds may persist for months, requiring surgical reconstruction.
• Fibrosis and contracture: Excess scar tissue can limit joint mobility, especially over joints.
• Secondary malignancy: High cumulative dose (> 30 Gy) slightly raises the risk of radiation‑induced skin cancer (estimated 0.5 % over 20 years).<sup>[4]</sup>
• Pain syndromes: Neuropathic pain may persist even after the skin heals.

When to Seek Emergency Care

References

1. American College of Radiology. ACR–SPR practice guideline for the performance of fluoroscopically guided interventional procedures. 2022.
2. International Commission on Radiological Protection (ICRP). Radiation Dose to Patients from Medical Imaging. ICRP Publication 135, 2020.
3. Clarke, A. et al. “Topical agents for radiation‑induced skin injury: A systematic review.” Cochrane Database of Systematic Reviews, 2020.
4. World Health Organization. Radiation and health: Risk of secondary cancers after radiotherapy. WHO, 2021.

```